Mutations in HFE causing hemochromatosis are associated with primary hypertriglyceridemia

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 11, 2009, Pages 4391-4397

  Solanas Barca, María ^a   Mateo Gallego, Rocío ^a   Calmarza, Pilar ^a   Jarauta, Estíbaliz ^a   Bea, Ana M ^a   Cenarro, Ana ^a   Civeira, Fernando ^a  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROL GROUP; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE; GENE MUTATION; GENETIC PREDISPOSITION; GENOTYPE; HEMOCHROMATOSIS; HFE GENE; HIGH RISK PATIENT; HUMAN; HYPERTRIGLYCERIDEMIA; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

EID: 70449086254     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0814     Document Type: Article

References (39)

1. Ford ES, Li C, Zhao G, Pearson WS, Mokdad AH 2009 Hypertriglyceridemia and its pharmacologic treatment among US adults. Arch Intern Med 169:572-578
2. Gómez-Gerique JA, Gutiérrez-Fuentes JA, Montoya MT, Porres A, Rueda A, Avellaneda A, Rubio MA 1999 Lipid profile of the Spanish population: the DRECE (diet and risk of cardiovascular disease in Spain) study. DRECE study group. Med Clin (Barc) 113:730-735
3. Third Report of the National Cholesterol Education Program (NCEP) 2002 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143-3421
4. Assmann G, Schulte H, Funke H, von Eckardstein A 1998 The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Eur Heart J 19:M8-M14 (Pubitemid 28470458)
5. Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V 2007 Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 115:450-458 (Pubitemid 46184196)
6. Dotevall A, Johansson S, Wilhelmsen L, Rosengren A 2004 Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study. Diabet Med 21:615-622
7. Grundy SM 1998 Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 81:18B-25B
8. Heller DA, de Faire U, Pedersen NL, Dahlén G, McClearn GE 1993 Genetic and environmental influences on serum lipid levels in twins. N Engl J Med 328:1150-1156 (Pubitemid 23105752)
9. Havel RJ, Kane JP 2001 Structure and metabolism of plasma lipoproteins. In: Scriver CR, Baudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2705-2716
10. Hopkins PN, Heiss G, Ellison RC, Province MA, Pankow JS, Eckfeldt JH, Hunt SC 2003 Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 108:519-523
11. Henneman P, Aulchenko YS, Frants RR, van Dijk KW, Oostra BA, van Duijn CM 2008 Prevalence and heritability of the metabolic syndrome and its individual components in a Dutch isolate: the Erasmus Rucphen Family study. J Med Genet 45:572-577
12. Jehn M, Clark JM, Guallar E 2004 Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 27:2422-2428 (Pubitemid 39281396)
13. Sun L, Franco OH, Hu FB, Cai L, Yu Z, Li H, Ye X, Qi Q, Wang J, Pan A, Liu Y, Lin X 2008 Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese. J Clin Endocrinol Metab 93:4690-4696
14. Jehn ML, Guallar E, Clark JM, Couper D, Duncan BB, Ballantyne CM, Hoogeveen RC, Harris ZL, Pankow JS 2007 A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 165:1047-1054 (Pubitemid 46598829)
15. Lecube A, Hernández C, Pelegrí D, SimóR2008 Factors accounting for high ferritin levels in obesity. Int J Obes (Lond) 32:1665-1669
16. Pietrangelo A 2004 Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 350:2383-2397 (Pubitemid 38702849)
17. Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, Anderson GJ, Southey MC, Giles GG, English DR, Hopper JL, Olynyk JK, Powell LW, Gertig DM 2008 Iron-overload- related disease in HFE hereditary hemochromatosis. N Engl J Med 358:221-230
18. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P; Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators 2005 Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 352:1769-1778 (Pubitemid 40570925)
19. Meriño-Ibarra E, Artieda M, Cenarro A, Goicoechea J, Calvo L, Guallar A, Civeira F 2005 Ultrasonography for the evaluation of visceral fat and the metabolic syndrome. Metabolism 54:1230-1235 (Pubitemid 41206884)
20. Junyent M, Gilabert R, Zambón D, Pocoví M, Mallén M, Cofán M, Núñez I, Civeira F, Tejedor D, Ros E 2008 Femoral atherosclerosis in heterozygous familial hypercholesterolemia: influence of the genetic defect. Arterioscler Thromb Vasc Biol 28:580-586
21. Yen AW, Fancher TL, Bowlus CL 2006 Revisiting hereditary hemochromatosis: current concepts and progress. Am J Med 119:391-399
22. Sánchez M, Villa M, Ingelmo M, Sanz C, Bruguera M, Ascaso C, Oliva R 2003 Population screening for hemochromatosis: a study in 5370 Spanish blood donors. J Hepatol 38:745-750 (Pubitemid 36613339)
23. Hegele RA, Pollex RL 2009 Hypertriglyceridemia: phenomics and genomics. Mol Cell Biochem 326:35-43
24. Wang WY, Barratt BJ, Clayton DG, Todd JA 2005 Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 6:109-118 (Pubitemid 40179533)
25. Sagoo GS, Tatt I, Salanti G, Butterworth AS, Sarwar N, van Maarle M, Jukema JW, Wiman B, Kastelein JJ, Bennet AM, de Faire U, Danesh J, Higgins JP 2008 Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am J Epidemiol 168:1233-1246
26. Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC 2002 Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11:3031-3038 (Pubitemid 35414816)
27. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS, Wahlstrand B, Hedner T, Corella D, Tai ES, Ordovas JM, Berglund G, Vartiainen E, Jousilahti P, Hedblad B, Taskinen MR, Newton-Cheh C, Salomaa V, Peltonen L, Groop L, Altshuler DM, Orho-Melander M 2008 Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40:189-197 (Pubitemid 351171402)
28. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, Kaplan L, Bennett D, Li Y, Tanaka T, Voight BF, Bonnycastle LL, Jackson AU, Crawford G, Surti A, Guiducci C, Burtt NP, Parish S, Clarke R, Zelenika D, Kubalanza KA, Morken MA, Scott LJ, Stringham HM, Galan P, Swift AJ, Kuusisto J, Bergman RN, Sundvall J, Laakso M, Ferrucci L, Scheet P, Sanna S, Uda M, Yang Q, Lunetta KL, Dupuis J, de Bakker PI, O'Donnell CJ, Chambers JC, Kooner JS, Hercberg S, Meneton P, Lakatta EG, Scuteri A, Schlessinger D, Tuomilehto J, Collins FS, Groop L, Altshuler D, Collins R, Lathrop GM, Melander O, Salomaa V, Peltonen L, Orho-Melander M, Ordovas JM, Boehnke M, Abecasis GR, Mohlke KL, Cupples LA 2009 Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41:56-65
29. Wang J, Ban MR, Zou GY, Cao H, Lin T, Kennedy BA, Anand S, Yusuf S, Huff MW, Pollex RL, Hegele RA 2008 Polygenic determinants of severe hypertriglyceridemia. Hum Mol Genet 17:2894-2899
30. Wang J, Cao H, Ban MR, Kennedy BA, Zhu S, Anand S, Yusuf S, Pollex RL, Hegele RA 2007 Resequencing genomic DNA of patients with severe hypertriglyceridemia (MIM 144650). Arterioscler Thromb Vasc Biol 27:2450-2455 (Pubitemid 350203963)
31. Lanktree MB, Anand SS, Yusuf S, Hegele RA 2009 Replication of genetic associations with plasma lipoprotein traits in a multiethnic sample. J Lipid Res 50:1487-1496
32. Silva M, Silva ME, de Paula H, Carneiro CM, Pedrosa ML 2008 Iron overload alters glucose homeostasis, causes liver steatosis, and increases serum triacylglycerols in rats. Nutr Res 28:391-398 (Pubitemid 351718472)
33. Kissebah AH, Alfarsi S, Adams PW 1981 Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Metabolism 30:856-868 (Pubitemid 11057485)
34. Civeira F, Jarauta E, Cenarro A, García-Otín AL, Tejedor D, Zambón D, Mallen M, Ros E, Pocoví M 2008 Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting. J Am Coll Cardiol 52:1546-1553
35. Phatak PD, Ryan DH, Cappuccio J, Oakes D, Braggins C, Provenzano K, Eberly S, Sham RL 2002 Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients. Blood Cells Mol Dis 29:41-47
36. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW 1999 A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341:718-724 (Pubitemid 29407371)
37. Aigner E, Theurl I, Theurl M, Lederer D, Haufe H, Dietze O, Strasser M, Datz C, Weiss G 2008 Pathways underlying iron accumulation in human nonalcoholic fatty liver disease. Am J Clin Nutr 87:1374-1383 (Pubitemid 351679780)
38. Brouwers MC, van Greevenbroek MM, Bilderbeek-Beckers MA, Robertus-Teunissen MG, van der Kallen CJ, Stehouwer CD, de Bruin TW 2007 Fatty liver-based identification of two distinct hypertriglyceridemic subgroups in familial combined hyperlipidemia. Metabolism 56:1311-1317
39. Pedersen P, Milman N 2009 Extrinsic factors modifying expressivity of the HFE variant C282Y, H63D, S65C phenotypes in 1,294 Danish men. Ann Hematol 88:957-965